NEW YORK (GenomeWeb News) – The University of Cambridge said today it has launched new multidisciplinary, collaborative research programs focused on synthetic biology and big data, as well as cardiovascular disease and public policy.

The university has added the four new subject areas into its Strategic Research Initiative program, which brings together academics from different disciplines to harness their expertise and make a “real-world impact,” Cambridge said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.